ABBOTT LABORATORIES Net Change in Cash 2007-2026 | ABT
Beta
What is net change in cash?
Net change in cash represents the total increase or decrease in cash and cash equivalents during the reporting period.
What is ABBOTT LABORATORIES's current net change in cash?
ABBOTT LABORATORIES (ABT) annual net change in cash for 2025 was $906.0M, a 25.83% increase from 2024. ABBOTT LABORATORIES net change in cash for the quarter ending March 31, 2026 was $-1.72B.
What was ABBOTT LABORATORIES's net change in cash in 2024?
ABBOTT LABORATORIES annual net change in cash for 2024 was $720.0M, a 124.11% increase from 2023.
What was ABBOTT LABORATORIES's net change in cash in 2023?
ABBOTT LABORATORIES annual net change in cash for 2023 was $-2.99B, a 3697.59% decline from 2022.
What is ABBOTT LABORATORIES's 5-year net change in cash CAGR?
ABBOTT LABORATORIES net change in cash grew at a compound annual growth rate (CAGR) of 21.18% from FY2020 to FY2025, going from $2.98B to $906.0M over 5 years.
Net Change in Cash History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR-21.2%
FY2020
$2.98B
→
FY2025
$906.0M
07080910111213141516171819202122232425
5 years selected
Net Change in Cash History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $906.0M | +25.8% | 10-K |
| FY2024 | $720.0M | +124.1% | 10-K |
| FY2023 | $-2.99B | -3697.6% | 10-K |
| FY2022 | $83.0M | -97.2% | 10-K |
| FY2021 | $2.96B | -0.6% | 10-K |
| FY2020 | $2.98B | +18512.5% | 10-K |
| FY2019 | $16.0M | +100.3% | 10-K |
| FY2018 | $-5.56B | +39.6% | 10-K |
| FY2017 | $-9.21B | -167.6% | 10-K |
| FY2016 | $13.62B | +1351.9% | 10-K |
| FY2015 | $938.0M | +59.5% | 10-K |
| FY2014 | $588.0M | +108.0% | 10-K |
| FY2013 | $-7.33B | -283.7% | 10-K |
| FY2012 | $3.99B | +26.0% | 10-K |
| FY2011 | $3.17B | +161.3% | 10-K |
| FY2010 | $-5.16B | -209.9% | 10-K |
| FY2009 | $4.70B | +183.7% | 10-K |
| FY2008 | $1.66B | -14.4% | 10-K |
| FY2007 | $1.94B | - | 10-K |
Company: ABBOTT LABORATORIESTicker: ABTSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →